N@N

Andrew Berens Downgraded (AGIO) to Hold and Decreased Target to $56 on, Sep 27th, 2024

Andrew Berens of Leerink Partners, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Hold and Decreased Target from $60 to $56 on, Sep 27th, 2024.

Andrew has made no other calls on AGIO in the last 4 months.

There are 4 other peers that have a rating on AGIO. Out of the 4 peers that are also analyzing AGIO, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Tessa Romero of "JP Morgan" Initiated at Hold and Held Target at $46 on, Thursday, June 13th, 2024
• Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $53 on, Tuesday, June 4th, 2024

These are the ratings of the 2 analyists that currently disagree with Andrew

---

• Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Friday, September 20th, 2024
• Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Thursday, September 19th, 2024

Contributing Sources

---